Kidney Cancer is a gold open access journal as of January 2023. This means that every article is immediately, permanently, and openly available for readers to view, download, share, and reuse. All articles published prior to 2023 are now available as open access under a CC license.
The APC for this journal is US$2800.
Authors may be eligible for discounts to their APC via open access agreements that Sage has with participating institutions. Discounts depend on the terms of the agreement, find out if your institution is participating by visiting the institutional agreements page at IOS Press. Eligibility is determined by the corresponding author’s affiliation at acceptance matching an agreement.
Your article may be eligible for a full or partial waiver due to our participation in initiatives to increase accessibility to publication across the international academic community. More information about discounts and eligibility.
PubMedCentral deposits
This journal deposits open access articles in PubMedCentral (PMC) as part of the IOS Press Open Library but can only do so if the article received NIH funding, or if any of the authors are affiliated with NIH, or associated with US Federal agency or private or international partners. Please refer the NIH Public Access Policy for the full list of participating funders and other details.
